Torrent Pharmaceuticals P/B Ratio
Torrent Pharmaceuticals (TORNTPHARM) P/B ratio is 22.78 (High), book value per share ₹1040.53 vs Healthcare average P/B of -0.31 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see TORNTPHARM screener.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
TORNTPHARM P/B Ratio — Valuation Insights & Book Value Analysis
Torrent Pharmaceuticals price-to-book ratio interpretation, valuation status and historical context — current P/B 22.78 (High). Review TORNTPHARM P/E ratio to evaluate earnings-based valuation against sector peers.
- Stock appears overvalued with PB of 22.78, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 278.2% above historical average
- Trading at premium to sector average PB of -0.31
Torrent Pharmaceuticals P/B Ratio Historical Trend
TORNTPHARM annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View TORNTPHARM price range for the annual high/low range and current price position.
TORNTPHARM Historical P/B Ratio — Book Value Per Share & Year-End Price
Torrent Pharmaceuticals annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 4.77 | ₹1040.53 | ₹4961.50 | ₹17,585 | High |
| 2025 | 8.57 | ₹449.17 | ₹3850.00 | ₹7,591 | High |
| 2024 | 8.28 | ₹405.68 | ₹3360.05 | ₹6,856 | High |
| 2023 | 6.29 | ₹366.75 | ₹2305.55 | ₹6,198 | High |
| 2022 | 2.21 | ₹700.35 | ₹1550.60 | ₹5,953 | Moderate |
TORNTPHARM vs Healthcare Peers — P/B Ratio Comparison
Torrent Pharmaceuticals P/B 22.78 vs Healthcare average -0.31, median 0.57 — range -14.47–1.1.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -14.47 | ₹18 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Parmax Pharma | PARMAX | -5.61 | ₹39 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.22 | ₹72 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.71 | ₹115 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.5 | ₹44 | Low |